Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 4
2005 2
2008 1
2009 3
2010 1
2011 1
2012 2
2013 1
2014 2
2016 1
2017 2
2018 1
2019 1
2020 3
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors.
Yeh SH, Chang WC, Hsu SM, Lin MH, Chung MC, Ke CS, Lee YC, Hwang CJ, Yang DJ. Yeh SH, et al. Among authors: lee yc. Cancer Biother Radiopharm. 2021 Sep 2. doi: 10.1089/cbr.2021.0169. Online ahead of print. Cancer Biother Radiopharm. 2021. PMID: 34491835
A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamide.
Kang IJ, Hsu SJ, Yang HY, Yeh TK, Lee CC, Lee YC, Tian YW, Song JS, Hsu TA, Chao YS, Yueh A, Chern JH. Kang IJ, et al. Among authors: lee yc. J Med Chem. 2017 Jan 12;60(1):228-247. doi: 10.1021/acs.jmedchem.6b00962. Epub 2016 Dec 28. J Med Chem. 2017. PMID: 27966956
Design, synthesis, and anti-HCV activity of thiourea compounds.
Kang IJ, Wang LW, Lee CC, Lee YC, Chao YS, Hsu TA, Chern JH. Kang IJ, et al. Among authors: lee yc. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1950-5. doi: 10.1016/j.bmcl.2009.02.048. Epub 2009 Feb 20. Bioorg Med Chem Lett. 2009. PMID: 19251415
26 results